Literature DB >> 6259954

Diabetes alters the myocardial cAMP-protein kinase cascade system.

W R Ingebretsen, C Peralta, M Monsher, L K Wagner, C G Ingebretsen.   

Abstract

An isolated perfused working rat heart preparation was used to assess the effect of alloxan-induced diabetes on the cAMP cascade system. Diabetes did not alter basal cAMP, cGMP content, or protein kinase or phosphorylase activities, but depressed (50%) isoproterenol-induced changes in cAMP content and protein kinase activity ratios. In contrast, phosphorylase activation and increased left ventricular pressure (LVP) were unaltered by diabetes. The relationship between cAMP and protein kinase activation is linear in hearts from both normal and diabetic rats. Diabetes did not alter this relationship. The relationship between protein kinase and phosphorylase activation or increases in LVP is also linear. An increase in the slopes obtained with diabetic hearts (P less than 0.05) was observed, suggesting an increased gain in the amplification cascade to protein kinase. The in vivo administration of insulin diminished this response. Thus, diabetes alters the ability of heart to accumulate cAMP and alters the gain of the amplification cascade system subsequent to protein kinase activation. This second effect may indicate an unmasking of a parallel regulatory pathway and in the beta-adrenergic regulation of phosphorylase activity and LVP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259954     DOI: 10.1152/ajpheart.1981.240.3.H375

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Serial changes in the myocardial beta-adrenergic signalling system in two models of non-insulin dependent diabetes mellitus.

Authors:  B Huisamen; E Marais; S Genade; A Lochner
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Chronic effects of streptozotocin diabetes on myocardial sensitivity in the rat.

Authors:  S Ramanadham; T E Tenner
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

3.  Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia.

Authors:  T S Trovik; A Vaartun; R Jorde; G Sager
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

4.  Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy.

Authors:  C E Heyliger; G N Pierce; P K Singal; R E Beamish; N S Dhalla
Journal:  Basic Res Cardiol       Date:  1982 Nov-Dec       Impact factor: 17.165

Review 5.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

6.  Acute insulin treatment normalizes the resistance to the cardiotoxic effect of isoproterenol in streptozotocin diabetic rats. A morphometric study of isoproterenol induced myocardial fibrosis.

Authors:  O Gøtzsche
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

7.  Post-receptor defect accounts for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.

Authors:  J A Buczek-Thomas; S R Jaspers; T B Miller
Journal:  Mol Cell Biochem       Date:  1992-11-04       Impact factor: 3.396

8.  Identification of the molecular basis for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.

Authors:  J A Buczek-Thomas; T B Miller
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

9.  Lack of cardiotoxic effect of isoproterenol in streptozotocin diabetic rats. A morphometric study of isoproterenol induced fibrosis.

Authors:  O Gøtzsche
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

Review 10.  Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart.

Authors:  Betul R Erdogan; Martin C Michel; Ebru Arioglu-Inan
Journal:  Cells       Date:  2020-11-26       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.